THE MYASTHENIA GRAVIS INEBILIZUMAB TRIAL (MINT): DESIGN OF RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDY OF AN ANTI-CD19 MONOCLONAL ANTIBODY IN GENERALIZED MYASTHENIA GRAVIS

被引：0
|
作者：
Nowak, R.
Benatar, M.
Ciafaloni, E.
Howard, J.
Leite, M.
Utsugisawa, K.
Vissing, J.
Wu, Y.
Abuhatzira, L.
Katz, E.
Ratchford, J.
机构：
来源：
MUSCLE & NERVE | 2020年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S115 / S115
页数：1
相关论文
共 50 条
  • [41] Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT)
    Sacca, Francesco
    Barnett, Carolina
    Vu, Tuan
    Peric, Stojan
    Phillips, Glenn A.
    Zhao, Sihui
    Qi, Cynthia Z.
    Gelinas, Deborah
    Chiroli, Silvia
    Verschuuren, Jan J. G. M.
    JOURNAL OF NEUROLOGY, 2023, 270 (04) : 2096 - 2105
  • [42] Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT)
    Francesco Saccà
    Carolina Barnett
    Tuan Vu
    Stojan Peric
    Glenn A. Phillips
    Sihui Zhao
    Cynthia Z. Qi
    Deborah Gelinas
    Silvia Chiroli
    Jan J. G. M. Verschuuren
    Journal of Neurology, 2023, 270 : 2096 - 2105
  • [43] EFFICACY AND SAFETY OF NIPOCALIMAB IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: TOPLINE RESULTS FROM THE DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED PHASE 3 VIVACITY-MG3 STUDY
    Vu, Tuan
    Antozzi, Carlo
    Ramchandren, Sindhu
    Nowak, Richard
    Farmakidis, Constantine
    Bril, Vera
    De Bleecker, Jan
    Yang, Huan
    Minks, Eduard
    Park, Jin-Sung
    Grudniak, Mariusz
    Smilowski, Marek
    Sevilla, Teresa
    Hoffmann, Sarah
    Sivakumar, Kumaraswamy
    Youssef, Eriene
    Sanga, Panna
    Karcher, Keith
    Zhu, Yaowei
    Ling, Leona
    Sun, Hong
    MUSCLE & NERVE, 2024, 70 (03) : 613 - 614
  • [44] Efficacy of Rozanolixizumab in Generalized Myasthenia Gravis: Subgroup Analyses from the Randomized Phase 3 MycarinG Study
    Vu, Tuan
    Druzdz, Artur
    Grosskreutz, Julian
    Habib, Ali A.
    Kaminski, Henry J.
    Mantegazza, Renato
    Utsugisawa, Kimiaki
    Vissing, John
    Beau-Lejdstrom, Raphaelle
    Boehnlein, Marion
    Gasalla, Teresa
    Grimson, Fiona
    Tarancon, Thais
    Bril, Vera
    NEUROLOGY, 2023, 100 (17)
  • [45] A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH AN OPEN-LABEL EXTENSION PERIOD TO EVALUATE THE EFFICACY AND SAFETY OF TELITACICEPT IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
    Vu, Tuan
    Cui, Xiaoming
    Fang, Jianmin
    Zuraw, Qing
    MUSCLE & NERVE, 2024, 70 (03) : 612 - 612
  • [46] Vivacity MG Phase 3 Study: Clinical Trial of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
    Ramchandren, S.
    Sanga, P.
    Burcklen, M.
    Sun, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 299 - 299
  • [47] VIVACITY MG PHASE 3 STUDY: CLINICAL TRIAL OF NIPOCALIMAB ADMINISTERED TO ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
    Ramchandren, Sindhu
    Sanga, Panna
    Burcklen, Michel
    Sun, Hong
    MUSCLE & NERVE, 2022, 66 : S51 - S51
  • [48] Vivacity MG Phase 3 Study: Clinical Trial of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
    Ramchandren, Sindhu
    Sanga, Panna
    Burcklen, Michel
    Sun, Hong
    NEUROLOGY, 2022, 99 (23) : S41 - S41
  • [49] A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF CYCLOSPORINE-A IN THE TREATMENT OF MYASTHENIA-GRAVIS
    TINDALL, RSA
    ROLLINS, JA
    PHILLIPS, JT
    GREENLEE, RG
    BELENDIUK, G
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 505 : 854 - 856
  • [50] CLINICAL IMPROVEMENT OF MYASTHENIA-GRAVIS BY TREATMENT WITH A CHIMERIC ANTI-CD4 MONOCLONAL-ANTIBODY
    AHLBERG, R
    YI, Q
    PIRSKANEN, R
    MATELL, G
    SWERUP, C
    RIEBER, P
    RIETHMULLER, G
    HOLM, G
    LEFVERT, AK
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 681 : 552 - 555
12345